CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome [Phase 1]
Summary
Phase 1 trial update of EYE001 for treating retinal tumors in patients with von Hippel-Lindau disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Eye Institute (NEI) | Conditions: Hippel-Lindau Disease | Phase 1 | Status: COMPLETED